The high cost of medical cannabis poses major obstacles for Canadian patients, even as recreational marijuana prices remain low, a new survey of thousands of Canadians suggests.
The finding comes as a slump in consumer spending on regulated medical cannabis in Canada continues, with Statistics Canada data showing sales worth 101 million Canadian dollars (roughly $75 million) in the fourth quarter of 2022.
ADVERTISEMENT
That CA$101 million figure represents a 3.8% decline from the same quarter in 2021 and a 34% tumble from the fourth quarter of 2018, when Canada legalized recreational cannabis.
It equals 7.5% of legal recreational cannabis spending in the fourth quarter of 2022.
The Medical Cannabis Access Survey released this month by a group of Canadian university researchers and medical marijuana patient groups surveyed 5,744 respondents over five months in 2022, mostly “daily consumers of medical cannabis with more than 10 years of
Read full article on Marijuana Business Daily
